...
首页> 外文期刊>Anaesthesia and intensive care >Safety of exposure of malignant hyperthermia non-susceptible patients and their relatives to anaesthetic triggering agents.
【24h】

Safety of exposure of malignant hyperthermia non-susceptible patients and their relatives to anaesthetic triggering agents.

机译:恶性高热不敏感患者及其亲属接触麻醉触发剂的安全性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

As the reliability of malignant hyperthermia normal in vitro contracture test results has been questioned, this study set out to determine the reliability of malignant hyperthermia normal results in New Zealand. Three hundred and twenty-nine anaesthetics were administered to malignant hyperthermia normal patients, identified through the Palmerston North Hospital malignant hyperthermia database. Anaesthetic records were retrieved and scrutinised for a malignant hyperthermia reaction using the Malignant Hyperthermia Clinical Grading Scale. Patients were exposed to one or more of eight triggering agents and multiple anaesthetic agents were administered in 41% of cases. Six variables were analysed, and although a minority of variables were abnormal in a small number of patients, none of the findings supported a malignant hyperthermia reaction. While the analysis was limited by the adequacy of the anaesthesia records, it was supported by negative DNA analysis in 55% of patients. This study supports several previous studies in demonstrating that patients in New Zealand tested non-susceptible to malignant hyperthermia can safely be given triggering agents.
机译:由于对恶性高热正常体外挛缩测试结果的可靠性提出了质疑,因此本研究旨在确定新西兰恶性高热正常结果的可靠性。通过帕默斯顿北部医院恶性高热数据库对恶性高热正常患者进行了329剂麻醉。检索麻醉记录并使用恶性高热临床评分量表仔细检查恶性高热反应。患者接触了八种触发剂中的一种或多种,​​在41%的病例中使用了多种麻醉剂。分析了六个变量,尽管少数患者中有少数变量异常,但没有发现支持恶性高热反应。尽管该分析受到麻醉记录是否足够的限制,但55%的患者的DNA阴性分析为该分析提供了支持。这项研究支持先前的几项研究,证明在新西兰接受过恶性高热不敏感测试的患者可以安全地服用触发剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号